CEFADYL Drug Patent Profile
When do Cefadyl patents expire, and what generic alternatives are available?
Cefadyl is a drug marketed by Apothecon and is included in four NDAs.
The generic ingredient in CEFADYL is cephapirin sodium. There is one drug master file entry for this compound. Additional details are available on the cephapirin sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEFADYL?
- What are the global sales for CEFADYL?
- What is Average Wholesale Price for CEFADYL?
Summary for CEFADYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 1,740 |
| DailyMed Link: | CEFADYL at DailyMed |
US Patents and Regulatory Information for CEFADYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | CEFADYL | cephapirin sodium | INJECTABLE;INJECTION | 061769-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | CEFADYL | cephapirin sodium | INJECTABLE;INJECTION | 062961-003 | Sep 20, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | CEFADYL | cephapirin sodium | INJECTABLE;INJECTION | 050446-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | CEFADYL | cephapirin sodium | INJECTABLE;INJECTION | 050446-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
